Giuseppe Caruso: ESMO Gynae 2026 Advancing ADCs in Ovarian Cancer
Giuseppe Caruso, Medical Consultant at IEO Istituto Europeo di Oncologia, shared a post on LinkedIn:
“One month to go until ESMO Gynae 2026 in Copenaghen. Excited to join as discussant on MIRV and the evolving role of ADCs in the platinum-eligible ovarian cancer setting.
What is happening in our field is truly a tsunami
We are playing a new board game with ADCs – ‘ADC-opoly’ – and reshaping treatment algorithms.
ESMO – European Society for Medical Oncology – OncoDaily – OncoAlert”
Fabian Trillsch, Deputy Director at LMU University Hospital Munich, shared Giuseppe Caruso’s post, adding:
“Indeed, Giuseppe Caruso this will be a great opportunity to put the upcoming data on ADCs for ovarian cancer in context.
Really looking forward to presenting the latest results of the AGO-OVAR 2.34/ MIROVA trial at ESMO Gynae 2026 and to discussing it with you and the audience!!
Great session, see you in Copenhagen!! 🤗 🇩🇰
ESMO – European Society for Medical Oncology
AGO Studiengruppe
ovarian cancer
ADC”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 23, 2026, 17:19Oluyemisi Famuyiwa: Financing Your Fertility Treatment
-
Aug 23, 2026, 17:11Favour Ayomi: The Questions That Changed Reproductive Science
-
Aug 23, 2026, 16:54Chang-Hoon Cho: A Comprehensive Immune Atlas of the Human Endometrium
-
Aug 23, 2026, 16:42Sharing Shannon’s Story with Preeclampsia This Story Saturday – Preeclampsia Foundation
-
Aug 23, 2026, 16:36Sarah Lewen: The More Capable the Machines Become, the More Human Connection Matters
-
Aug 23, 2026, 16:31Chandana AÖ‰ Why Good-Quality Embryos Sometimes Don’t Implant
-
Aug 23, 2026, 16:28Negin AsadiÖ‰ How Does the Blastocyst Attach to the Uterus?
-
Aug 23, 2026, 16:22Christopher RobinsonÖ‰ Ultrasound Images of Scar and Cesarean Scar Defects
-
Aug 23, 2026, 16:17Somya JhaÖ‰ ICSI – 1 Sperm, 1 Egg, 1 Tiny Needle
